Patents Assigned to C V Technologies Inc.
  • Processes of making North American ginseng fractions, products containing them, and use as immunomodulators
    Patent number: 7067160
    Abstract: This invention is directed towards processes of making fractions from North American ginseng and to compositions containing these fractions. This invention is also directed towards methods of methods of preparing pharmaceuticals containing these fractions. Additionally, this invention is directed towards methods of stimulating the production of immunoglobins by administering fractions of this invention and also to methods of activating B-lymphocyte proliferation and antibody production by administering fractions of this invention. This invention is also directed towards a method of stimulating the production of IL-16, IL-1, and/or TNF-? in cells by administering a fraction of this invention.
    Type: Grant
    Filed: July 2, 2002
    Date of Patent: June 27, 2006
    Assignee: C V Technologies Inc.
    Inventors: Jacqueline J. Shan, Peter K. T. Pang, Buhan Huang, Lei Ling
  • Processes of making north american ginseng fractions, products containing them, and use as immunomodulators
    Publication number: 20050196471
    Abstract: The invention is directed to chemical processes of preparing fractions form North American ginseng (Panax quinquefolium) and pharmaceutical compositions containing these fractions. The products of the present invention may be used to stimulate the production of cytokines and/or antibodies, or as therapeutics targeted at conditions characterized by low immunity, such as the common cold, influenza, chronic fatigue syndrome, AIDS and cancer.
    Type: Application
    Filed: April 26, 2005
    Publication date: September 8, 2005
    Applicant: C V Technologies Inc.
    Inventors: Jacqueline Shan, Peter Pang, Buhan Huang, Lei Ling
  • Preparation derived from shark cartilage for treatment of diseased related to excessive PHF or excessive intracellular calcium
    Publication number: 20040234617
    Abstract: A preparation derived from shark cartilage for the treatment of diseases related to excessive PHF or Excessive intracellular calcium.
    Type: Application
    Filed: April 16, 2004
    Publication date: November 25, 2004
    Applicant: C. V. Technologies, Inc.
    Inventors: Peter K.T. Pang, Jacqueline J. Shan, Kam Chiu
  • Processes of making North American ginseng fractions, products containing them, and uses as immunomodulators
    Publication number: 20040137087
    Abstract: The invention is directed to chemical processes of preparing fractions from North American ginseng (Panax quinquefolium) and pharmaceutical compositions containing these fractions. The products of the present invention may be used to stimulate the production of cytokines and/or antibodies, or as therapeutics targeted at conditions characterized by low immunity, such as the common cold, influenza, chronic fatigue syndrome, AIDS and cancer.
    Type: Application
    Filed: October 23, 2003
    Publication date: July 15, 2004
    Applicant: C.V. Technologies, Inc.
    Inventors: Jacqueline J. Shan, Peter K. T. Pang, Buhan Huang, Lei Ling
  • Processes of making North American ginseng fractions, products containing them, and use as immunomodulators
    Publication number: 20030077341
    Abstract: The invention is directed to chemical processes of preparing fractions from North American ginseng (Panax quinquefolium) and pharmaceutical compositions containing these fractions. The products of the present invention may be used to stimulate the production of cytokines and/or antibodies, or as therapeutics targeted at conditions characterized by low immunity, such as the common cold, influenza, chronic fatigue syndrome, AIDS and cancer.
    Type: Application
    Filed: July 2, 2002
    Publication date: April 24, 2003
    Applicant: C.V. Technologies, Inc.
    Inventors: Jacqueline J. Shan, Peter K. T. Pang, Buhan Huang, Lei Ling
  • Processes of making north american ginseng fractions, products containing them, and use as immunomodulators
    Patent number: 6432454
    Abstract: The invention is directed to chemical processes of preparing fractions from North American ginseng (Panax quinquefolium) and pharmaceutical compositions containing these fractions. The products of the present invention may be used to stimulate the production of cytokines and/or antibodies, or as therapeutics targeted at conditions characterized by low immunity, such as the common cold, influenza, chronic fatigue syndrome, AIDS and cancer.
    Type: Grant
    Filed: July 27, 2000
    Date of Patent: August 13, 2002
    Assignee: C. V. Technologies, Inc.
    Inventors: Jacqueline J. Shan, Peter K. T. Pang, Buhan Huang, Lei Ling